Richard Attias & Associates Appoints Peter Hall as Global President & CEORIYADH, Saudi Arabia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Richard Attias & Associates (RA&A Group) announced the appointment of Peter Hall as Global President & CEO, effective October 1, 2026.
Quantisimo Corp., the Pure-Play Sovereign Quantum Vertical Platform “Root to Qubit” Formed by WISeQey and SEALSQ, Signs Definitive Business Combination Agreement with GigCapital8 Corp. to Become a Nasdaq-Listed Public CompanyQuantisimo Corp., the Pure-Play Sovereign Quantum Vertical Platform “Root to Qubit” Formed by WISeQey and SEALSQ, Signs Definitive Business Combination Agreement with GigCapital8 Corp. to Become a Nasdaq-Listed Public Company
PALESTINIAN REFORM ADVOCATE SAMER SINIJLAWI TELLS THE NEWS FORUM: "88% of eligible Palestinian voters have already preregistered for the November 28th election — the first election since 2005"In an exclusive interview with The News Forum, Samer Sinijlawi calls for a new generation of Palestinian leadership, peaceful coexistence with Israel and a democratic, demilitarized Palestinian state
Retension Pharmaceuticals Announces Pricing of Initial Public OfferingFALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (Nasdaq: RTSN) (“Retension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases, announced today the pricing of its upsized initial public offering of 3,750,000 shares of its common stock at an initial public offering price of $12.00 per share. The gross proceeds to Retension from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Retension, are expected to be $45.0 million. All shares of common stock are being offered by Retension. Retension has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on or about October 13, 2026, subject to the satisfaction of customary closing conditions. The shares are expected to begin trading on October 9, 2026 on the Nasdaq Capital Market under the ticker symbol “RTSN.”
TRexBio Announces Pricing of Initial Public OfferingSOUTH SAN FRANCISCO, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. (“TRexBio”) (Nasdaq: TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today announced the pricing of its initial public offering of 8,333,334 shares of its common stock at an initial public offering price of $14.00 per share. All of the shares are being offered by TRexBio. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $116.7 million. TRexBio’s common stock is expected to begin trading on the Nasdaq Global Select Market on October 9, 2026, under the ticker symbol “TRXB”. The offering is expected to close on October 13, 2026, subject to the satisfaction of customary closing conditions. In addition, TRexBio has granted the underwriters a 30-day option to purchase up to an additional 1,250,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The LancetZUG, Switzerland, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated angioedema, such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that results of RAPIDe-3, a phase 3, global, randomized, double-blind, placebo-controlled crossover study evaluating oral deucrictibant immediate-release (IR) capsule (20 mg) for the on-demand treatment of HAE attacks in adolescents and adults have been published in The Lancet (Journal Impact Factor: 109.0).
Bitdeer AI Expands Southeast Asia Footprint with A901, a New 67MW AI Data Center Campus in Malaysia; Active AI Cloud Pipeline Exceeds $10 Billion67MW expansion brings Bitdeer AI’s secured AI Cloud data center capacity to approximately 273.5MW, or approximately 78% of its target of up to 350MW to be delivered by the first quarter of 2028
California Waste Solutions Makes More Than 100 Community Donations Since 2020, With Covid-19 Relief and a $5 Million Fulbright Commitment Among Defining Acts of GivingCalifornia Waste Solutions & Founder David Duong organized Vietnam manufacturing of masks and oxygen gear when supplies ran short, then kept a six-year pattern of local giving across Oakland and San Jose.
Portillo’s Announces Third Quarter 2026 Earnings WebcastOAK BROOK, Ill., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Portillo’s, Inc. (
NASDAQ: PTLO) announces the following event:
Avalanche Energy and TRIDEC Advance Plans for First Global Fusion Machine Manufacturing Facility in the Tri-CitiesLandmark project will establish a world-class advanced manufacturing center, create hundreds of long-term jobs and position the Tri-Cities and Washington state as a global hub for fusion technology
York Space Systems Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against York Space Systems, Inc. – YSSNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against York Space Systems, Inc. (“York Space Systems” or the “Company”) (
NYSE: YSS), if they purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.
NOTICE TO DISREGARD -- Bitdeer Technologies GroupSINGAPORE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- We are advised by Bitdeer Technologies Group that journalists and other readers should disregard the news release, “Bitdeer AI Secures 60MW A103 Facility at Its Existing Cyberjaya, Malaysia Campus; Reaches Approximately 95% of Its Up-to-350MW Target Capacity” issued earlier today, over GlobeNewswire.
Honeywell Aerospace Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Honeywell Aerospace, Inc. - HONANEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against Honeywell Aerospace, Inc. (“Honeywell Aerospace” or the “Company”) (NasdaqGS: HONA), if they purchased or otherwise acquired Honeywell Aerospace, Inc. securities between June 29, 2026 and September 1, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.
Simply Good Foods Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Simply Good Foods Company – SMPLNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased Simply Good shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Veea Regains Full Compliance with Nasdaq Continued Listing RequirementsBoard and committee changes resolve remaining governance matters following unexpected board vacancy
Gray Announces Closing of Term Loan and Revolving Credit Facility RefinancingATLANTA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Gray Media, Inc. (“Gray”) (
NYSE: GTN) announced today that it has closed a new $600 million Term Loan G maturing July 15, 2030 and has reduced its existing $750 million revolving credit facility to $680 million and extended the maturity date from December 1, 2028 to July 15, 2030. The Term Loan G was priced at a margin of 350 basis points over the Standard Overnight Financing Rate and issued with an original issue discount of 0.5%. The pricing grid on the extended revolving credit facility remains unchanged. Proceeds from the Term Loan G were used to repay a portion of Gray’s existing Term Loan D maturing December 1, 2028, leaving $150 million aggregate principal amount outstanding, and to pay related fees and expenses.
Namib Minerals Completes Commissioning of Expanded Milling Plant at How MineNew York, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Namib Minerals ("Namib" or "the Company") (Nasdaq: NAMM), today announced the completion of commissioning of its expanded milling plant at How Mine. The Company notes the commissioning is ahead of the mid-October deadline previously communicated.
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMSNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (
NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
HDFC Bank Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against HDFC Bank Limited - HDBNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against HDFC Bank Limited (“HDFC” or the “Company”) (
NYSE: HDB), if they purchased HDFC securities between July 17, 2023 and May 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
AEVEX Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against AEVEX Corp. - AVEXNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against AEVEX Corp. (“Aevex” or the “Company”) (
NYSE: AVEX), if they purchased or otherwise acquired Aevex’s publicly traded Class A common stock between April 17, 2026 and June 4, 2026, inclusive (the “Class Period”) and/or pursuant or traceable to the registration statement and prospectus (the “IPO Offering Documents”) issued in connection with Aevex’s April 17, 2026 initial public offering (“IPO”). This action is pending in the United States District Court for the Southern District of California.
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNXNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherwise acquired the Company’s common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Bombardier Expands Top-Industry Ranked Support Network with New Line Maintenance Station in Sydney, Australia, Further Enhancing Care and Convenience for Customers in Asia-PacificMONTREAL, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Bombardier today announced the addition of a new Line Maintenance Station (LMS) in Sydney, Australia, bringing additional care and convenience to customers in Asia-Pacific (APAC). The Sydney LMS complements Bombardier’s existing Australian network, which includes a LMS in Perth and service centre in Melbourne.
Magna International Inc. Announces Date For Third Quarter 2026 Results WebcastAURORA, Ontario, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (
NYSE:MGA)
Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts in CMS 2027 Star RatingsThree contracts achieve 4.5-Star ratings as Alignment remains focused on delivering high-quality, coordinated care for seniors
ATG Capital Announces that the Delaware Supreme Court has Affirmed the Chancery Court’s Ruling in Empery Digital Appeal – Upholding Stockholder FranchiseDelaware Supreme Court Affirms the Delaware Chancery Court’s Ruling that ATG Capital’s Nomination is Valid and Orders that the Judgment for ATG Capital Stands
Clever Care Health Plan Achieves 4.5-Star Medicare Advantage Rating from CMS for Star Year 2027The rating arrives as Clever Care achieves significant growth and unveils its new benefits for 2027
Weatherford Expands Collaboration with Equinor Through Contract Extension and Major Offshore Completions AwardHOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (
NASDAQ: WFRD) ("Weatherford" or the "Company") today announced it has been awarded a two-year extension across several strategic frame agreements with Equinor, one of the world's leading energy companies.
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis ConferencePreviously disclosed post hoc PreciSION CF analyses of SION-719 support advancement of SION-451 + SION-2222 into the AscenSION CF Phase 2a proof-of-concept trial
Bitdeer AI Secures 60MW A103 Facility at Its Existing Cyberjaya, Malaysia Campus; Reaches Approximately 95% of Its Up-to-350MW Target CapacityWith A103, Bitdeer AI’s secured AI Cloud data center capacity totals approximately 333.5MW of its target of up to 350MW, to be delivered by the first quarter of 2028
Dan Ives Publishes the Latest Ives AI 30 Research, Identifying the Next Wave of AI OpportunitiesWedbush Fund Advisers prepares the Dan IVES Wedbush AI Revolution ETF (
NYSE: IVES) for its rebalance as Dan Ives, of Yorkville Ives, continues to produce the Ives AI 30 research behind the ETF
Enact to Host Third Quarter 2026 Earnings Call November 5thRALEIGH, N.C., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its third quarter earnings release after the market closes on November 4, 2026. Enact will host a conference call to review third quarter 2026 financial results on November 5, 2026 at 8:00 a.m. (ET).
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New ZealandTAIRĀWHITI, New Zealand and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Rua Bioscience Limited (NZX: RUA) (“Rua”) and PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla”) announce that Rua and PharmAla Biotech Inc., a subsidiary of PharmAla, have signed a distribution and licence agreement. Under the agreement, Rua will import, distribute and sell PharmAla’s pharmaceutical-grade LaNeo™ MDMA in New Zealand.
FinWise Bancorp to Host Third Quarter 2026 Earnings Conference Call and Webcast on Wednesday, October 28, 2026MURRAY, Utah, Oct. 08, 2026 (GLOBE NEWSWIRE) -- FinWise Bancorp (
NASDAQ: FINW) (“FinWise” or the “Company”), the parent company of FinWise Bank, today announced that it will report its third quarter 2026 results and host a conference call and webcast after the market close on Wednesday, October 28, 2026.
Barnes & Noble Education Highlights Continued Business Transformation and Milestone Balance Sheet ProgressCompany ends fiscal September with no outstanding revolving credit borrowings and positive cash on hand for the first time since 2019
Alpine Banks of Colorado announces common shareholder dividendGLENWOOD SPRINGS, Colo., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Alpine Banks of Colorado (OTCQX: ALPIB), parent company of Alpine Bank, declared a cash dividend of $0.23 per share of Class A common stock and $0.23 per share of Class B common stock, payable October 26, 2026, to shareholders of record as of October 19, 2026.
QuantumScape Announces Timing of Third Quarter 2026 Business Results and WebcastSAN JOSE, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (
NASDAQ: QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced it will release its 2026 third-quarter business results after market close on Wednesday, October 21, 2026. This will be followed by a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time).
YYForce Expands 24iFM With Services Marketplace and Lifestyle AdvertisingSINGAPORE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (
NASDAQ: YFOR) (“YYForce” or the “Company”), an AI-enabled workforce management platform and integrated facility management (“IFM”) provider operating across Asia and beyond, today announced the commercial expansion of 24iFM through its Services Marketplace and Lifestyle advertising capabilities (the “Expansion”). The Expansion brings estate administration, on-demand household services and merchant promotions together in one digital platform.The Expansion introduces two potential digital revenue channels alongside YYForce’s existing IFM operations: commissions or service fees from qualifying completed marketplace transactions, and advertising and promotional revenue from participating merchants. Revenue generation will depend on user adoption, completed transactions and commercial agreements with providers and merchants.
Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation-- Open-Label Extension (OLE) Data of STENOVA Phase 2a study with ontunisertib in Fibrostenosing Crohn’s disease (FSCD) selected for oral presentation at UEG Week 2026 --
Matternet to Participate in Upcoming Investor ConferencesMOUNTAIN VIEW, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Matternet, Inc. (OTCQB: MTTN) (“Matternet” or the “Company”), the first publicly traded pure-play drone delivery company, today announced that management will participate in the following upcoming investor conferences:
AppFolio, Inc. Announces Date of Third Quarter 2026 Financial Results Conference CallSANTA BARBARA, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- AppFolio, Inc. (
NASDAQ: APPF) today announced that it will report its third quarter 2026 financial results after the close of the U.S. financial markets on Thursday, October 22, 2026.
Applied Materials and UCLA Engineering Accelerate Semiconductor Innovation at the EPIC CenterSANTA CLARA, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that the UCLA Samueli School of Engineering will join the company’s EPIC Center in Silicon Valley as a research partner. Together with Applied’s scientists and engineers, UCLA researchers will work to solve semiconductor materials and integration challenges with a focus on shortening the time it takes to bring breakthrough research to commercialization.
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development ProgramCompany is working to deploy 19-amino-acid detection into a developmental sequencing kit and remains confident in demonstrating detection of all 20 amino acids by year-end 2026
Altus Group to Release Q3 2026 Financial Results on November 5TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”, “Altus” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today the following investor updates:
Postal Realty Trust, Inc. to Report Third Quarter 2026 Financial Results on November 3, 2026CEDARHURST, N.Y., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (
NYSE: PSTL) (the “Company”), a publicly traded REIT focused on acquiring and managing critical logistics infrastructure primarily leased to the US Postal Service (the “USPS”), announced today that it will report its third quarter 2026 financial results on Tuesday, November 3, 2026, after market close.
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026MENLO PARK, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2026 financial results for the period ended October 2, 2026 following the close of the market on Thursday, October 29, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026FREMONT, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report financial results for the third quarter 2026 after market close on Tuesday, November 3, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Circana’s 2026 Holiday Study Finds Consumers Spending Selectively, Not Stepping AwayHoliday spending forecast to range from down 1% to up 2.5% as shoppers seek value, convenience, and experiences worth prioritizing
Sezzle to Announce Third Quarter 2026 Results and Participate in Upcoming Investor ConferencesMinneapolis, MN, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (
NASDAQ: SEZL) (Sezzle or Company) // Sezzle will release its third quarter 2026 results after the market close on November 4, 2026. The Company will host a conference call and webcast at 5:00 p.m. ET that same day. The earnings presentation will be available shortly after market close via the Company’s Investor Relations page. Investors are encouraged to submit questions in advance of the call by emailing investorrelations@sezzle.com.
CSX Corporation Declares Quarterly DividendJACKSONVILLE, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (
NASDAQ: CSX) announced that the Company’s Board of Directors approved a $0.14 per share quarterly dividend on the Company’s common stock. The dividend is payable Dec. 15, 2026, to shareholders of record at the close of business Nov. 30, 2026.
Lakefront Receives Transparency Notification from Bank of AmericaMechelen, Belgium; October 8, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Bank of America.
ROHM Showcases Technologies Powering AI, Next-Generation Mobility and Industrial Innovation at electronica 2026Santa Clara, CA and Kyoto, Japan, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ROHM Semiconductor Europe today announced it will return to electronica 2026, taking place from 10 to 13 November 2026 in Munich, Germany. Visitors can meet the ROHM team at Hall C3, Booth 520, where the company will showcase its latest power and analog semiconductor solutions for AI infrastructure, electric mobility, industrial automation, and next-generation electronic systems.
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLCWARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with HRK Healthcare LLC (“HRK”).
Moomoo Launches Real-Time* Deposit Capabilities Through Visa and Checkout.comNew Apple Pay and Google Pay deposit options enable eligible users to fund their accounts in real-time*, 24/7
New Survey Finds Student Withdrawals Are a Growing and Costly Challenge for CollegesInstitutions increasingly understand why students withdraw, but many are still figuring out how to protect students and manage the financial impact.
UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Unicycive Therapeutics, Inc. Investors with Large Losses to Contact the Firm Seeking Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options
BBNX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beta Bionics (BBNX) To Contact Him Directly To Discuss Their Options
FuelCell Energy, Inc. Investors Have Until November 10th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In FuelCell (FCEL) To Contact Him Directly To Discuss Their Options
